Intelligent Batch Epitope Identification and Partitioning: an intelligent tool for the identification of B cell dominant epitopes.

Publication date: Jul 02, 2025

Identifying B cell dominant epitopes helps to improve vaccine design and better understand immune evasion of pathogens. Herein, we present the Intelligent Batch Epitope Identification and Partitioning (IBEIP), an intelligent tool for identifying B cell dominant epitope regions based on antigen-neutralizing antibody (Ag-nAb) complex data. IBEIP can accurately map the epitopes on any appointed Ag-nAb complex by analyzing antigen-antibody interactions at a molecular level. Combined with a hierarchical iterative merging model, IBEIP can intelligently merge and analyze mapped epitopes to identify B cell dominant epitopes. It is also applicable to analyzing high-mutant antigens and complex epitope structures. We demonstrated the performance of IBEIP by analyzing 127 Ag-nAb complexes from the respiratory syncytial virus (RSV) fusion, SARS-CoV-2 spike, and high-mutant influenza hemagglutinin. Over 90% of the residues overlapped between IBEIP and reported epitopes, confirming its reliability. IBEIP also uncovered new and important B cell dominant epitope regions and structures of these pathogens for researchers. Our study provides a reliable, intelligent tool for B cell dominant epitope analysis and offers some valuable insights for preventing RSV, SARS-CoV-2, and influenza infections.

Open Access PDF

Concepts Keywords
Bioinform Antibodies, Neutralizing
Intelligent Antibodies, Neutralizing
Mutant Antibodies, Viral
Syncytial Antibodies, Viral
Vaccine antigen antibody complex
COVID-19
Epitope Mapping
Epitopes, B-Lymphocyte
Epitopes, B-Lymphocyte
Humans
Immunodominant Epitopes
Immunodominant Epitopes
influenza hemagglutinin
RSV fusion
SARS-CoV-2
SARS-CoV-2 spike
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2

Semantics

Type Source Name
disease IDO cell
drug DRUGBANK Tropicamide
disease MESH influenza
disease MESH infections
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
pathway REACTOME Translation
disease IDO site
disease IDO pathogen
disease IDO infection
drug DRUGBANK Glycine
disease IDO immunodeficiency
disease IDO process
disease IDO protein
disease IDO immune response
disease MESH tumor escape
disease MESH SARS CoV 2 infection
disease IDO object
disease MESH Allergy
drug DRUGBANK Methylergometrine

Original Article

(Visited 1 times, 1 visits today)